SeaSpine reports $34.2M in Q2 revenue: 6 things to know

Written by Laura Dyrda | August 04, 2017 | Print  |

SeaSpine reported 3 percent revenue increase in the second quarter of 2017.


Here are six key points:


1. SeaSpine's revenue hit $34.2 million for the second quarter, a 3 percent year over year increase. U.S. revenue was up 1.1 percent to $30.4 million, driven by $16 million in U.S. orthobiologics revenue. The U.S. spinal instrumentation revenue hit $14.4 million.


2. International revenue jumped 20.5 percent year over year to $3.8 million.


3. During the second quarter, SeaSpine launched the Mariner Posterior Fixation System, a modular pedicle screw system used during posterior lumbar fixation, and the limited commercial launch of Skipjack Expandable Interbody System, designed to provide in-situ expansion for height or lordosis.


4. Net loss reached $8 million, less than $12 million reported for the second quarter last year. Operating expenses reached $28.4 million, down from $31.5 million due to lower selling, general and administration as well as intangible amortization expenses.


5. The company reported $12.3 million cash on hand and $4 million of outstanding borrowing against a $30 million credit facility.


6. SeaSpine expects full year revenue to reach $130 million to $133 million, a 1 percent to 3 percent growth over 2016.


More articles on orthopedic devices:

Stryker names new board member: 4 insights
LongueVue Capital acquires Zavation Medical Products: 5 insights
Smith & Nephew, Zimmer Biomet, NuVasive & more: 13 device company key notes

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months